Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BXL6: Variant p.Arg151Gln

Caspase recruitment domain-containing protein 14
Gene: CARD14
Feedback?
Variant information Variant position: help 151 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glutamine (Q) at position 151 (R151Q, p.Arg151Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In PSORS2; uncertain significance; decreases NF-kappaB transcription factor activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 151 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1004 The length of the canonical sequence.
Location on the sequence: help AIGSLQEELNQEKGQKEVLL R RCQQLQEHLGLAETRAEGLH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         AIGSLQEELNQEKGQKEVLLRRCQQLQEHLGLAETRAEGLH

Mouse                         AISSLQEELAQEKAQKEVLLRRCQQLKERLGLAEAHAEGLR

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1004 Caspase recruitment domain-containing protein 14
Coiled coil 128 – 409
Alternative sequence 1 – 237 Missing. In isoform 3.



Literature citations
CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M.; Jordan C.T.; Cao L.; Lim E.; Bouchlaka Souissi C.; Jrad A.; Omrane I.; Kouidhi S.; Zaraa I.; Anbunathan H.; Mokni M.; Doss N.; Guttman-Yassky E.; El Gaaied A.B.; Menter A.; Bowcock A.M.;
Br. J. Dermatol. 174:330-337(2016)
Cited for: VARIANTS PSORS2 TRP-69; SER-117; GLN-151; TRP-151; LYS-197; PRO-209; THR-216; ALA-420; LEU-602 AND GLY-639; CHARACTERIZATION OF VARIANTS PSORS2 TRP-69; SER-117; ARG-150; GLN-151; TRP-151; LYS-197; PRO-209; THR-216; ALA-420; LEU-602 AND GLY-639; VARIANTS GLN-62; ARG-150; ASN-200; THR-216; CYS-218; VAL-338; PRO-350 AND PRO-357; CHARACTERIZATION OF VARIANTS CYS-218 AND VAL-338;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.